About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 1NCT00207155

An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer

The purpose of this study is to predict response to Erbitux as a single agent in patients with metastatic colon cancer

Lead sponsor: Eli Lilly and Company•12 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Eli Lilly and Company

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Measurable disease Tumor available for biopsies. Life expectancy of at least 3 months.

Exclusion Criteria

•Known or documented brain metastases prior to Cetuximab therapy.

Related studies

RECRUITINGPhase 2

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

NCT07446322 · Ras-mutated Metastatic Colorectal Cancer, mCRC, and more

Assessing the Efficacy and Safety of ctDNA-driven Selection for Anti-EGFR Retreatment in a Real World Metastatic Colorectal Cancer Patients Cohort (the REalCHALLENGE Study)

NCT07536113 · Metastatic Colorectal Cancer (CRC)

RECRUITINGPhase 1

A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)

NCT07416552 · Metastatic Colorectal Cancer

RECRUITINGPhase 3

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

NCT07228832 · Metastatic Colorectal Cancer (CRC)

RECRUITINGPhase 1

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

NCT06625775 · Solid Tumor, Adult, Metastatic Breast Cancer, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 28, 2015Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment110

Start dateDec 2003

Last updatedOct 28, 2015

Condition

Metastatic Colorectal Cancer

Locations shown

Local Institution

Duarte, California

Local Institution

Tampa, Florida

Local Institution

Baltimore, Maryland

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 28, 2015Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions